— Know what they know.
Not Investment Advice

AMPH NASDAQ

Amphastar Pharmaceuticals, Inc.
1W: +5.0% 1M: -13.5% 3M: -36.4% YTD: -31.4% 1Y: -27.6% 3Y: -57.7% 5Y: -9.1%
$18.41
+0.25 (+1.38%)
 
Weekly Expected Move ±12.5%
$13 $15 $17 $19 $21
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Strong Sell · Power 30 · $811.8M mcap · 33M float · 1.89% daily turnover · Short 52% of daily vol

📊 Key Metrics

TTM
$721M
Revenue
-1.1% YoY
$79M
Net Income
-44.1% YoY
$135M
Free Cash Flow
-10.0% YoY
41.1%
Gross Margin
8.0%
Op. Margin
3.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE10.4%
ROA4.9%
ROIC7.7%

Valuation

P/E10.4
P/B1.1
EV/EBITDA8.2

Leverage

Debt/Equity0.83
Current Ratio4.02
Interest Cov.4.9x

Quality Scores

Piotroski F6/9
Altman Z2.27
Beneish M-2.63

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms